These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10669788)

  • 1. Aggregation of an amyloidogenic fragment of human islet amyloid polypeptide.
    Rhoades E; Agarwal J; Gafni A
    Biochim Biophys Acta; 2000 Feb; 1476(2):230-8. PubMed ID: 10669788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micelle formation by a fragment of human islet amyloid polypeptide.
    Rhoades E; Gafni A
    Biophys J; 2003 May; 84(5):3480-7. PubMed ID: 12719273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly.
    Xu Y; Maya-Martinez R; Guthertz N; Heath GR; Manfield IW; Breeze AL; Sobott F; Foster R; Radford SE
    Nat Commun; 2022 Feb; 13(1):1040. PubMed ID: 35210421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity.
    Esser N; Hogan MF; Templin AT; Akter R; Fountaine BS; Castillo JJ; El-Osta A; Manathunga L; Zhyvoloup A; Raleigh DP; Zraika S; Hull RL; Kahn SE
    Diabetologia; 2024 Sep; 67(9):1897-1911. PubMed ID: 39245780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
    Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
    J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide.
    de Koning EJ; Morris ER; Hofhuis FM; Posthuma G; Höppener JW; Morris JF; Capel PJ; Clark A; Verbeek JS
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8467-71. PubMed ID: 8078905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet amyloid polypeptide inserts into phospholipid monolayers as monomer.
    Engel MF; Yigittop H; Elgersma RC; Rijkers DT; Liskamp RM; de Kruijff B; Höppener JW; Antoinette Killian J
    J Mol Biol; 2006 Feb; 356(3):783-9. PubMed ID: 16403520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus.
    Caillon L; Hoffmann AR; Botz A; Khemtemourian L
    J Diabetes Res; 2016; 2016():5639875. PubMed ID: 26636105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide.
    Mazor Y; Gilead S; Benhar I; Gazit E
    J Mol Biol; 2002 Oct; 322(5):1013-24. PubMed ID: 12367525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties.
    Tenidis K; Waldner M; Bernhagen J; Fischle W; Bergmann M; Weber M; Merkle ML; Voelter W; Brunner H; Kapurniotu A
    J Mol Biol; 2000 Jan; 295(4):1055-71. PubMed ID: 10656810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural studies and cytotoxicity assays of "aggregation-prone" IAPP(8-16) and its non-amyloidogenic variants suggest its important role in fibrillogenesis and cytotoxicity of human amylin.
    Louros NN; Tsiolaki PL; Zompra AA; Pappa EV; Magafa V; Pairas G; Cordopatis P; Cheimonidou C; Trougakos IP; Iconomidou VA; Hamodrakas SJ
    Biopolymers; 2015 May; 104(3):196-205. PubMed ID: 25913357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azadirachtin inhibits amyloid formation, disaggregates pre-formed fibrils and protects pancreatic β-cells from human islet amyloid polypeptide/amylin-induced cytotoxicity.
    Dubey R; Patil K; Dantu SC; Sardesai DM; Bhatia P; Malik N; Acharya JD; Sarkar S; Ghosh S; Chakrabarti R; Sharma S; Kumar A
    Biochem J; 2019 Mar; 476(5):889-907. PubMed ID: 30814273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myricetin protects pancreatic β-cells from human islet amyloid polypeptide (hIAPP) induced cytotoxicity and restores islet function.
    Dubey R; Kulkarni SH; Dantu SC; Panigrahi R; Sardesai DM; Malik N; Acharya JD; Chugh J; Sharma S; Kumar A
    Biol Chem; 2021 Jan; 402(2):179-194. PubMed ID: 33544469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal fragment of human islet amyloid polypeptide is non-fibrillogenic in the presence of membranes and does not cause leakage of bilayers of physiologically relevant lipid composition.
    Khemtémourian L; Engel MF; Liskamp RM; Höppener JW; Killian JA
    Biochim Biophys Acta; 2010 Sep; 1798(9):1805-11. PubMed ID: 20570648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
    Jaikaran ET; Nilsson MR; Clark A
    Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of islet amyloid polypeptide to supported lipid bilayers and amyloid aggregation at the membranes.
    Sasahara K; Morigaki K; Okazaki T; Hamada D
    Biochemistry; 2012 Sep; 51(35):6908-19. PubMed ID: 22876830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
    Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
    Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.
    Jaikaran ET; Clark A
    Biochim Biophys Acta; 2001 Nov; 1537(3):179-203. PubMed ID: 11731221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.
    Andrikopoulos S; Verchere CB; Terauchi Y; Kadowaki T; Kahn SE
    Diabetes; 2000 Dec; 49(12):2056-62. PubMed ID: 11118007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hIAPP Amyloid Aggregation and Pancreatic β-Cell Toxicity by OH-Terminated PAMAM Dendrimer.
    Gurzov EN; Wang B; Pilkington EH; Chen P; Kakinen A; Stanley WJ; Litwak SA; Hanssen EG; Davis TP; Ding F; Ke PC
    Small; 2016 Mar; 12(12):1615-26. PubMed ID: 26808649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.